Purpose
To assess long-term renal function and micturition pattern of males submitted to transurethral resection of the prostate (TURP) for moderate-to-severe lower urinary tract symptoms (LUTS) ...after renal transplantation (RT). To investigate the role of clinical and urodynamic (UD) parameters for bladder outlet obstruction (BOO) diagnosis in these patients.
Methods
Retrospective data analysis of ≥ 50 years old patients who underwent RT between 01/2005 and 12/2016. Patients with moderate-to-severe LUTS after RT who underwent a urologic evaluation and a UD study were included. TURP was performed in case of BOO diagnosis. Kidney function and micturition patterns were evaluated before, 3, 12, 24, 36, and 48 months after TURP. Predictors of BOO were assessed at univariable and multivariable logistic regression models. Statistical analysis was performed with STATA16.
Results
233 male patients ≥ 50 years underwent RT. 71/233 (30%) patients developed voiding LUTS. 52/71 (73%) patients with moderate-to-severe LUTS underwent UD. TURP was performed in 36/52 (69%) patients, with BOO diagnosis. Median (interquartile range) follow-up was 108 (75–136) months. Maximum flow at flowmetry (Qmax), International Prostate Symptom Score and post-voided residual volume improved significantly after surgery. Serum creatinine decreased and glomerular filtration rate improved significantly at follow-up, especially when TURP was performed ≤ 6 months from RT. At the multivariable model, bladder capacity ≥ 300 mL (OR = 1.74, CI 95% 1.03–3.15,
p
= 0.043) and detrusor pressure at Qmax (OR = 2.05, CI 95% 1.48–3.02,
p
= 0.035) were the independent predictors of BOO.
Conclusion
RT patients with moderate-to-severe LUTS at risk for BOO and graft failure are better identified by UD than clinical parameters. Bladder capacity and voiding pressure are key for the early diagnosis of BOO.
To assess the relevance of the endoscopic evaluation in clinically suspected cases of Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC), using ESSIC criteria, established in 2008 by the European ...Society for the Study of Interstitial Cystitis (ESSIC).
We included all patients who underwent endoscopic evaluation between January 01, 2015 and October 31, 2019 for clinical suspicion of BPS/IC. Collected data included demographic and baseline clinical features, endoscopic appearance (prior and after hydrodistension), and bladder wall biopsy results, both defined according to ESSIC criteria. Data were cross tabulated to define ESSIC phenotypes, while subgroups and multivariate analyses were carried out to assess the influence of clinical variables on ESSIC phenotypes.
Fifty-two subjects were included, mainly women (92%). Median age at evaluation was 45 (32.9-58.2) years. At hydrodistension, 21 patients (42%) had positive and 29 (58%) had negative findings. Grade 2-3 glomerulations were found in 18 patients, while Hunner lesions were reported only in 1 patient. Positive results at biopsy were found in 24 pts (51.1%), while negative in 23 (48.9%). Overall, the positive and negative concordance between hydrodistension and biopsy results was 78%. No significant differences in ESSIC subtypes were found after stratification based on clinical features and at multivariate analysis. Retrospective design is the main limitation.
Cystoscopy with hydrodistension and biopsy do have a role in the diagnostic pathway of BPS/IC. However, results should be considered in the clinical context of the individual patient.
The gold standard treatment for high-risk NMIBC is BCG immunotherapy. Some studies suggested an immomodulatory effects for commonly used drugs (ie, ACE-I and ARBs). We aimed to determine whether ...these drugs impact the prognosis of patients with high-risk NMIBC treated with BCG.
Retrospective analysis on 208 patients from a single academic center with primary high-risk NMIBC treated with transurethral resection followed by 6 weekly instillations of BCG and up to 12 monthly maintenance instillations. ARBs or ACE-I use at the time of treatment initiation was recorded. Inverse probability of treatment weighting (IPTW) was used to adjust for clinical and pathological covariates. IPTW–adjusted Kaplan-Meier curves and weighted Cox proportional hazards regression were used to compare 2-yr failure-free (2-yr FFS), failure-free (FFS), overall recurrence-free (RFS) and progression-free survival (PFS).
A total of 68 patients were on ACE-I, and 38 on ARBs and treatment respectively. At a median follow-up of 26 months, ACE-I treatment had no significant impact on cancer-related outcomes. Conversely, patients treated with ARBs experienced significant improvements in 2-yr FFS (HR 0.3; 0.1-0.9, P = .004), FFS (HR 0.4, 0.1-0.9, P = .005), and PFS (HR 0.001; < 0.001-0.001, P < .001). No significant impact was found for ARB use in RFS (HR 0.6; P = .09). Sensitivity analyses confirmed these results.
our findings support a potential role of the angiotensin-renin system in bladder cancer development. We identified ARBs as potential beneficial drugs that seems to act in synergy with BCG-immunotherapy.
The best treatment option for high-risk non muscle-invasive bladder cancer is BCG immunotherapy. In this study we looked for potential interaction between drugs with known immunomodulatory effects (angiotensin receptor blockers and ACE-inhibitors) and cancer recurrence in patients treated with BCG. Our results show a benefit in patients treated with angiotensin receptor blockers.
Purpose
The purpose of any surgical repair of pelvic organ prolapse (POP) is to
restore pelvic anatomy, preserving urinary, intestinal and sexual functions
while avoiding complications. We present a ...novel robotic approach to
hysterosacropexy (HSP) in the treatment of POP.
Methods
In our technique (named ‘Cupid and Psyche’, recalling as it does the famous
sculpture by Canova), the two branches of the MESH encircle the uterus from
behind, lifting and supporting it.
The aim of this technique is to resolve POP, minimizing the risk of vaginal
erosion: the posterior ‘embrace’ of the uterus limits the direct contact of
the mesh with the vagina, thus reducing any risk of erosion/extrusion at
this level. We performed 10 cases of robotic HSP.
Results
All procedures are completed robotically. Median operative time
(skin-to-skin) is 125 min interquartile range (IQR) 85-145, including port
placement, robot docking and console time. We have never had any cases of
intraoperative or postoperative complications.
With regard to short-term follow-up, analysis of outcomes is limited; in any
case, we have never had any cases of MESH erosion or other complications,
and no sexually active woman complained of dyspareunia.
Conclusions
Maintaining sufficient motility of the vagina is another advantage of ‘Cupid
and Psyche’, avoiding as it does any negative effects on patients’ later
sexual activity, granting more natural motility of both uterus and vagina
but resolving the prolapse.
Further prospective studies comparing the long-term functional outcomes of
the various HSP techniques are needed to confirm these findings.
PDF
